research Reduced Plakoglobin Increases the Risk of Sodium Current Defects and Atrial Conduction Abnormalities in Response to Androgenic Anabolic Steroid Abuse
Reduced plakoglobin and steroid abuse increase the risk of heart rhythm issues.
Search
forLearn
0 / 0 results — no results
Research
5 / 1000+ results
research Is Androgenetic Alopecia a Marker of Arrhythmia? A Case-Control Study
Men with androgenetic alopecia may have a higher risk of heart rhythm problems.
research Androgenic Alopecia Is Associated With Increased Arterial Stiffness in Asymptomatic Young Adults
Hair loss in young adults is linked to harder arteries.
research Male Sex Hormone and Reduced Plakoglobin Jointly Impair Atrial Conduction and Cardiac Sodium Currents
Male hormones and reduced plakoglobin can impair heart electrical function and increase arrhythmia risk in males.
research Towards the Development of AgoKirs: New Pharmacological Activators to Study Kir2.x Channel and Target Cardiac Disease
New compounds may help treat heart disease by activating specific potassium channels.
Community Join
5 / 78 resultscommunity The Biggest Concern That I Have For Oral Minoxidil: Cardiac Hypertrophy
Oral minoxidil can cause serious heart issues like cardiac hypertrophy and arrhythmias, prompting some users to reduce dosage or switch to topical treatments. Despite significant hair regrowth, side effects such as shortness of breath and chest pains are common concerns.
community Its just getting worse and worse
A 26-year-old is experiencing hair loss despite using minoxidil and dutasteride. Suggestions include shaving his head, trying oral minoxidil, or considering a hair transplant.
community Has anyone done research on Absci's AI‑driven antibody platform? Seeking your thoughts!
A user is interested in Absci's AI-driven antibody platform, ABS-201, for treating androgenetic alopecia, which shows promising preclinical results and potential for hair regrowth and pigmentation restoration. However, concerns are raised about the drug's development timeline and its advantages compared to existing treatments.
community Petition Alert: Let's Get PP405 Phase 3 Trials in Germany by 2026!
A user is advocating for Phase 3 trials of the hair loss treatment PP405 to be conducted in Germany, citing benefits like a diverse patient base and faster access for European patients. Despite skepticism about the petition's influence, the user believes it can demonstrate significant interest and potentially influence strategic decisions.
community Microneedling and minoxidil alone
A physician experienced hair thickening and new growth using microneedling and minoxidil, but stopped using topical finasteride due to side effects like reduced libido and erectile dysfunction. The physician plans to continue with microneedling and minoxidil, considering finasteride nonessential for cosmetic purposes.